NO301985B1 - Fremgangsmåte for fremstilling av 3-des-hydroksy-cystatin C eller en homolog derav, plasmid samt mikroorganisme for anvendelse ved utförelse av fremgangsmåten - Google Patents

Fremgangsmåte for fremstilling av 3-des-hydroksy-cystatin C eller en homolog derav, plasmid samt mikroorganisme for anvendelse ved utförelse av fremgangsmåten Download PDF

Info

Publication number
NO301985B1
NO301985B1 NO890260A NO890260A NO301985B1 NO 301985 B1 NO301985 B1 NO 301985B1 NO 890260 A NO890260 A NO 890260A NO 890260 A NO890260 A NO 890260A NO 301985 B1 NO301985 B1 NO 301985B1
Authority
NO
Norway
Prior art keywords
cystatin
des
plasmid
sequence
hydroxy
Prior art date
Application number
NO890260A
Other languages
English (en)
Norwegian (no)
Other versions
NO890260D0 (no
NO890260L (no
Inventor
Anders Grubb
Aake Lundwall
Magnus Abrahamson
Henrik Dalboege
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO890260D0 publication Critical patent/NO890260D0/no
Publication of NO890260L publication Critical patent/NO890260L/no
Publication of NO301985B1 publication Critical patent/NO301985B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Electronic Switches (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO890260A 1987-05-22 1989-01-20 Fremgangsmåte for fremstilling av 3-des-hydroksy-cystatin C eller en homolog derav, plasmid samt mikroorganisme for anvendelse ved utförelse av fremgangsmåten NO301985B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK260987A DK260987D0 (da) 1987-05-22 1987-05-22 Fremgangsmaade til fremstilling af et humant protein samt dna-sekvens til anvendelse ved udoevelse af fremgangsmaaden
PCT/DK1988/000082 WO1988009384A1 (en) 1987-05-22 1988-05-20 Method of producing cystatin c or modifications hereof and dna-sequence for use when carrying out the method

Publications (3)

Publication Number Publication Date
NO890260D0 NO890260D0 (no) 1989-01-20
NO890260L NO890260L (no) 1989-01-20
NO301985B1 true NO301985B1 (no) 1998-01-05

Family

ID=8113675

Family Applications (1)

Application Number Title Priority Date Filing Date
NO890260A NO301985B1 (no) 1987-05-22 1989-01-20 Fremgangsmåte for fremstilling av 3-des-hydroksy-cystatin C eller en homolog derav, plasmid samt mikroorganisme for anvendelse ved utförelse av fremgangsmåten

Country Status (12)

Country Link
EP (1) EP0362259B1 (de)
JP (1) JP3011274B2 (de)
AT (1) ATE135049T1 (de)
AU (1) AU619750B2 (de)
CA (1) CA1340862C (de)
DE (1) DE3855078T2 (de)
DK (1) DK260987D0 (de)
ES (1) ES2013337A6 (de)
FI (1) FI102191B (de)
IL (1) IL86476A (de)
NO (1) NO301985B1 (de)
WO (1) WO1988009384A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2002820A1 (en) * 1988-11-18 1990-05-18 Kazunori Hanada Pharmaceutical use for cystatins
GB9122051D0 (en) * 1991-10-17 1991-11-27 Univ Nottingham Medicines
GB9403819D0 (en) * 1994-02-28 1994-04-20 Univ Leeds Control of parasites
AU738766B2 (en) * 1994-11-21 2001-09-27 University Of Leeds, The Modified proteinase inhibitors
RU2182598C2 (ru) * 1994-11-21 2002-05-20 Новартис Аг Модифицированные ингибиторы протеиназы
US6011012A (en) 1995-06-05 2000-01-04 Human Genome Sciences, Inc. Human cystatin E
CA2223888A1 (en) * 1995-06-05 1996-12-12 Human Genome Sciences, Inc. Human cystatin e
EP1123399A2 (de) * 1998-08-05 2001-08-16 The University Of British Columbia Herstellung und verwendung von modifizierten cystatinen
AU2178000A (en) * 1998-12-11 2000-06-26 Salk Institute For Biological Studies, The Co-factors for trophic factors, and methods of use thereof
EP1176200A3 (de) 2000-06-20 2005-01-12 Switch Biotech Aktiengesellschaft Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankung oder Wundheilung sowie ihre Verwendung zur Indentifizierung von pharmakologisch aktiven Substanzen
KR20180084159A (ko) * 2012-07-31 2018-07-24 유키지루시 메그밀크 가부시키가이샤 신규 단백질 소재
CN102895658A (zh) * 2012-08-23 2013-01-30 苏州大学附属第一医院 Cystatin C在治疗蛛网膜下腔出血后发生的脑血管痉挛的应用
CN106119286A (zh) * 2016-08-10 2016-11-16 吴江近岸蛋白质科技有限公司 表达载体及其高效表达和制备人胱抑素c蛋白的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775624A (en) * 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C

Also Published As

Publication number Publication date
ATE135049T1 (de) 1996-03-15
IL86476A0 (en) 1988-11-15
EP0362259B1 (de) 1996-03-06
WO1988009384A1 (en) 1988-12-01
DE3855078D1 (de) 1996-04-11
JP3011274B2 (ja) 2000-02-21
CA1340862C (en) 1999-12-28
AU619750B2 (en) 1992-02-06
DK260987D0 (da) 1987-05-22
AU1939988A (en) 1988-12-21
IL86476A (en) 1994-01-25
FI102191B1 (fi) 1998-10-30
JPH03501201A (ja) 1991-03-22
FI895553A0 (fi) 1989-11-21
EP0362259A1 (de) 1990-04-11
DE3855078T2 (de) 1996-07-18
NO890260D0 (no) 1989-01-20
NO890260L (no) 1989-01-20
ES2013337A6 (es) 1990-05-01
FI102191B (fi) 1998-10-30

Similar Documents

Publication Publication Date Title
US6774107B1 (en) Protein for blocking platelet adhesion
JPH0687778B2 (ja) ヒト抗トロンビン▲ｉｉｉ▼
Nilsson et al. A signal peptide with a proline next to the cleavage site inhibits leader peptidase when present in a sec‐independent protein
NO301480B1 (no) Fremgangsmåte for enzymatisk fremstilling av basisk fibroblastfaktor
Elce et al. The effects of truncations of the small subunit on m-calpain activity and heterodimer formation
US5332804A (en) High molecular weight human angiogenic basic fibroblast growth factors
NO303735B1 (no) Fremgangsmöte for fremstilling av en hirudinanalog, samt DNA-sekvens, sekresjonsvektor og transformerte mikroorganismer som inneholder vektoren
WO1992000325A1 (fr) Polypeptides anticoagulants
JPH01104178A (ja) エンケファリナーゼの製造方法、アッセイ法およびそれを含有する医薬組成物
EP0362259B1 (de) Verfahren zur herstellung von cystatin-c oder abwandlungen davon und dns-sequenz zur ausführung dieser methode
WO1992007935A1 (en) Glycosaminoglycan-targeted fusion proteins, their design, construction and compositions
JP2000074922A (ja) シュードモナス・アエルギノザの外部膜タンパク質ｆ
US5432264A (en) Recombinant 3-des-OH-cystatin C produced by expression in a procaryotic host cell
McILHINNEY et al. Characterization of a polyhistidine‐tagged form of human myristoyl‐CoA: protein N‐myristoyltransferase produced in Escherichia coli
EP0251730A2 (de) Herstellung von menschlichem Lysozym
CN101506226A (zh) 改良的色素上皮衍生因子变体及其用途
DK172400B1 (da) Fremgangsmåde til fremstilling af renset minactivin, minactivinkodende DNA-molekyle, rekombinant DNA-molekyle, sammensmeltet gen, vært, reagent til lokalisering og definering af grænserne for tumorer i histologiske prøver, samt anvendelse af det rekombinante DNA-molekyle, minactivinet og peptider deraf
CA1339875C (en) Modified human psti
US5188943A (en) Method of producing high molecular weight human fibroblast growth factors
WO1994029448A1 (en) Dna and protein coded for thereby
Isono et al. Mutation leading to gene fusion in the histidine operon of Salmonella typhimurium
TW200906433A (en) Therapeutic agent for acute hepatitis or prophylactic and/or therapeutic agent for fulminant hepatitis
US7993893B2 (en) Haemocoagulase
EP0322084A2 (de) Tumorzellenhemmender Faktor
NO864442L (no) Mutantkodende sekvens.

Legal Events

Date Code Title Description
MK1K Patent expired